Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-24-005284

Chief Financial Officer acquired 1,787 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Moran Sean F. Chief Financial Officer 2024-04-10 Option exercise +1,787 $30.00 $53,610 48,605 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Moran Sean F. Chief Financial Officer 2024-04-10 Option exercise · Employee Stock Option (right to buy) −1,787 0 D: show line 2 in the form
Loading xslF345X05/doc4.xml…